Final Report - EUCAAD (European Consortium for Anticancer Antibody Development)
Project ID: 200755Funded under: FP7-HEALTH
This is the final report for the EUCAAD project which had the overall objective of defining novel target structures and generating new antibodies that may be used for therapy of cancers. The two fundamental types of cancer-associated molecules targeted in the course of the EUCAAD project molecules related to tumour angiogenesis and tumour-associated antigens. It covers the key achievements of the project and includes an image of the project logo and a description of the potential impact.
Download application/zip (451756)
Record Number: 13967 / Last updated on: 2013-01-18